GBM28 GBM Model

GBM28, a Patient-Derived Xenograft (PDX) model, is an essential tool for brain cancer research. Explore its unique characteristics to advance our understanding of the disease and discover new treatments. PDX models like GBM28 are indispensable in preclinical drug discovery for their ability to replicate the patient’s tumor environment. Researchers can use GBM28 to screen potential drug candidates, assess their efficacy, and identify the most promising treatments. GBM28 accelerates the drug development process, bringing hope to brain cancer patients.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM28
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide), Radiation (2Gy)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM28 Survival

Survival of orthotopic intracranial implanted  GBM28 in Nu/Nu mice  (n=10)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content